VHsquared Ltd.
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Private
- Established
- 2010-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.vhsquared.com
Open-label V565 Target Engagement Study
Phase 1
Completed
- Conditions
- Ulcerative Colitis
- Interventions
- Biological: V565
- First Posted Date
- 2018-10-15
- Last Posted Date
- 2018-10-15
- Lead Sponsor
- VHsquared Ltd.
- Target Recruit Count
- 5
- Registration Number
- NCT03705117
- Locations
- π¬π§
The Royal London Hospital, London, United Kingdom
A First Time in Human Study in Healthy Volunteers and Patients
- First Posted Date
- 2017-01-05
- Last Posted Date
- 2017-01-05
- Lead Sponsor
- VHsquared Ltd.
- Target Recruit Count
- 47
- Registration Number
- NCT03010787
- Locations
- π¬π§
Quintiles Drug Research Unit at Guy's Hospital, Quintiles Ltd, London, United Kingdom
A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease
- First Posted Date
- 2016-11-29
- Last Posted Date
- 2021-12-22
- Lead Sponsor
- VHsquared Ltd.
- Target Recruit Count
- 125
- Registration Number
- NCT02976129
- Locations
- π¦πΉ
Klinikum Wels Grieskirchen, Wels, Austria
π³π±Maastricht University Medical Center, Maastricht, Netherlands
π΅π±Specjalistyczna Praktyka, Sopot, Poland
Β© Copyright 2025. All Rights Reserved by MedPath